Research output per year
Research output per year
Fingerprint
Dive into the research topics where Sandra Tuyaerts is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Baiden-Amissah, R. E. M., Annibali, D., Tuyaerts, S. & Amant, F., 7 Aug 2021, In : Cancers. 13, 16, 17 p., 3988.Research output: Contribution to journal › Article
-
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
De Wispelaere, W., Annibali, D., Tuyaerts, S., Lambrechts, D. & Amant, F., 1 May 2021, In : Cancers. 13, 9, 15 p., 2040.Research output: Contribution to journal › Article
-
S2-106 Talimogene laherparepvec (T-VEC)-induced tumor oncolysate as a source of tumor antigens and maturation factors for blood-isolated myeloid dendritic cells
Tijtgat, J., De Munck, J., Dufait, I., Schwarze, J. K., Breckpot, K., Neyns, B., Aerts, J. & Tuyaerts, S., 11 May 2021.Research output: Unpublished contribution to conference › Poster
File3 Downloads (Pure) -
65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Schwarze, J. K., Bertels, C., Awada, G., Tijtgat, J., Tuyaerts, S., Cras, L., Vaeyens, F., Vanbinst, A-M., Everaert, H., Michotte, A., Caljon, B., Olsen, C., Janssen, T., Van Dooren, S., Forsyth, R., Duerinck, J. & Neyns, B., Dec 2020, In : Annals of Oncology. 31, S7, p. S1443-S1443Research output: Contribution to journal › Meeting abstract (Journal)
-
Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial Cancer
Marinelli, O., Annibali, D., Morelli, M. B., Zeppa, L., Tuyaerts, S., Aguzzi, C., Amantini, C., Maggi, F., Ferretti, B., Santoni, G., Amant, F. & Nabissi, M., 28 Oct 2020, In : Frontiers in Oncology. 10, 15 p., 538064.Research output: Contribution to journal › Article
1 Citation (Scopus)
Activities
- 1 Talk or presentation at a conference
-
A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Julia Katharina Schwarze (Presenter), Jens Tijtgat (Contributor), Gil Awada (Contributor), Louise Cras (Contributor), Inès Dufait (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor)17 Sep 2021Activity: Talk or presentation › Talk or presentation at a conference